<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9825769</article-id>
    <article-id pub-id-type="pmid">36477791</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btac783</article-id>
    <article-id pub-id-type="publisher-id">btac783</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Original Paper</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Databases and Ontologies</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CanMethdb: a database for genome-wide DNA methylation annotation in cancers</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Zhao</surname>
          <given-names>Jianmei</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>College of Life Sciences, Northeast Forestry University</institution>, Harbin 150038, <country country="CN">China</country></aff>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, Daqing 163711, <country country="CN">China</country></aff>
        <xref rid="btac783-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Qian</surname>
          <given-names>Fengcui</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Computer, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>Department of Cell Biology and Genetics, School of Basic Medical Sciences, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <xref rid="btac783-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Xuecang</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, Daqing 163711, <country country="CN">China</country></aff>
        <xref rid="btac783-FM1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yu</surname>
          <given-names>Zhengmin</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Computer, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhu</surname>
          <given-names>Jiang</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, Daqing 163711, <country country="CN">China</country></aff>
        <aff><institution>College of Information and Computer Engineering, Northeast Forestry University</institution>, Harbin 150038, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yu</surname>
          <given-names>Rui</given-names>
        </name>
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150088, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhao</surname>
          <given-names>Yue</given-names>
        </name>
        <aff><institution>College of Bioinformatics Science and Technology, Harbin Medical University</institution>, Harbin 150088, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ding</surname>
          <given-names>Ke</given-names>
        </name>
        <aff><institution>College of Information and Computer Engineering, Northeast Forestry University</institution>, Harbin 150038, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Yanyu</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, Daqing 163711, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yang</surname>
          <given-names>Yongsan</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, Daqing 163711, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pan</surname>
          <given-names>Qi</given-names>
        </name>
        <aff><institution>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Department of Rheumatology, Zhon gshan Hospital, Fudan University</institution>, Shanghai 200433, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chen</surname>
          <given-names>Jiaxin</given-names>
        </name>
        <aff><institution>Shenzhen Bay Laboratory, Pingshan Translational Medicine Center</institution>, Shenzhen 518118, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Song</surname>
          <given-names>Chao</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Computer, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Qiuyu</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Computer, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Jian</given-names>
        </name>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, Daqing 163711, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7381-2374</contrib-id>
        <name>
          <surname>Wang</surname>
          <given-names>Guohua</given-names>
        </name>
        <aff><institution>College of Life Sciences, Northeast Forestry University</institution>, Harbin 150038, <country country="CN">China</country></aff>
        <aff><institution>College of Information and Computer Engineering, Northeast Forestry University</institution>, Harbin 150038, <country country="CN">China</country></aff>
        <xref rid="btac783-cor1" ref-type="corresp"/>
        <!--ghwang@nefu.edu.cn-->
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4700-5496</contrib-id>
        <name>
          <surname>Li</surname>
          <given-names>Chunquan</given-names>
        </name>
        <aff><institution>The First Affiliated Hospital, Department of Cardiology, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>School of Medical Informatics, Daqing Campus, Harbin Medical University</institution>, Daqing 163711, <country country="CN">China</country></aff>
        <aff><institution>School of Computer, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>The First Affiliated Hospital, Cardiovascular Lab of Big Data and Imaging Artificial Intelligence, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <aff><institution>Department of Cell Biology and Genetics, School of Basic Medical Sciences, Hengyang Medical School, University of South China</institution>, Hengyang 421001, <country country="CN">China</country></aff>
        <xref rid="btac783-cor1" ref-type="corresp"/>
        <!--lcqbio@163.com-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Valencia</surname>
          <given-names>Alfonso</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <fn id="btac783-FM1">
        <p>The authors wish it to be known that, in their opinion, Jianmei Zhao, Fengcui Qian and Xuecang Li authors should be regarded as Joint First Authors.</p>
      </fn>
      <corresp id="btac783-cor1">To whom correspondence should be addressed. <email>lcqbio@163.com</email> or <email>ghwang@nefu.edu.cn</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <month>1</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-12-07">
      <day>07</day>
      <month>12</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>07</day>
      <month>12</month>
      <year>2022</year>
    </pub-date>
    <volume>39</volume>
    <issue>1</issue>
    <elocation-id>btac783</elocation-id>
    <history>
      <date date-type="received">
        <day>11</day>
        <month>8</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>30</day>
        <month>10</month>
        <year>2022</year>
      </date>
      <date date-type="editorial-decision">
        <day>20</day>
        <month>11</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>06</day>
        <month>12</month>
        <year>2022</year>
      </date>
      <date date-type="corrected-typeset">
        <day>23</day>
        <month>12</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btac783.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>DNA methylation within gene body and promoters in cancer cells is well documented. An increasing number of studies showed that cytosine–phosphate–guanine (CpG) sites falling within other regulatory elements could also regulate target gene activation, mainly by affecting transcription factors (TFs) binding in human cancers. This led to the urgent need for comprehensively and effectively collecting distinct <italic toggle="yes">cis</italic>-regulatory elements and TF-binding sites (TFBS) to annotate DNA methylation regulation.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>We developed a database (CanMethdb, <ext-link xlink:href="http://meth.liclab.net/CanMethdb/" ext-link-type="uri">http://meth.liclab.net/CanMethdb/</ext-link>) that focused on the upstream and downstream annotations for CpG–genes in cancers. This included upstream <italic toggle="yes">cis-</italic>regulatory elements, especially those involving distal regions to genes, and TFBS annotations for the CpGs and downstream functional annotations for the target genes, computed through integrating abundant DNA methylation and gene expression profiles in diverse cancers. Users could inquire CpG–target gene pairs for a cancer type through inputting a genomic region, a CpG, a gene name, or select hypo/hypermethylated CpG sets. The current version of CanMethdb documented a total of 38 986 060 CpG–target gene pairs (with 6 769 130 unique pairs), involving 385 217 CpGs and 18 044 target genes, abundant <italic toggle="yes">cis</italic>-regulatory elements and TFs for 33 TCGA cancer types. CanMethdb might help biologists perform in-depth studies of target gene regulations based on DNA methylations in cancer.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>The main program is available at <ext-link xlink:href="https://github.com/chunquanlipathway/CanMethdb" ext-link-type="uri">https://github.com/chunquanlipathway/CanMethdb</ext-link>.</p>
      </sec>
      <sec id="s5">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>62171166</award-id>
        <award-id>62272212</award-id>
        <award-id>62225109</award-id>
        <award-id>62072095</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="8"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>DNA methylation has been widely described to regulate gene expression in cancer (<xref rid="btac783-B10" ref-type="bibr">Chen <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btac783-B19" ref-type="bibr">Dor and Cedar, 2018</xref>; <xref rid="btac783-B20" ref-type="bibr">Ganesh <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btac783-B26" ref-type="bibr">Hu <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btac783-B41" ref-type="bibr">Maurano <italic toggle="yes">et al.</italic>, 2015</xref>). In general, hypermethylation is considered to decrease the activity of distinct regulatory elements, including proximal and distal regulatory regions, by reducing accessibility and transcription factor (TF) binding, and subsequent target gene expressions in various cancers (<xref rid="btac783-B2" ref-type="bibr">Aran <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btac783-B7" ref-type="bibr">Boyes and Bird, 1991</xref>; <xref rid="btac783-B9" ref-type="bibr">Chen <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btac783-B50" ref-type="bibr">Silva <italic toggle="yes">et al.</italic>, 2022</xref>; <xref rid="btac783-B61" ref-type="bibr">Yao <italic toggle="yes">et al.</italic>, 2015</xref>). DNA methylation at gene promoters and cytosine–phosphate–guanine (CpG) islands (CGIs) were originally recognized to be associated with gene expression levels (<xref rid="btac783-B31" ref-type="bibr">Klose and Bird, 2006</xref>). A large number of recent studies have focused on DNA methylation in more DNA element classes. For instance, it was reported that DNA methylation at enhancers, regulatory elements localized distal to the transcription start sites (TSS) (<xref rid="btac783-B53" ref-type="bibr">Thurman <italic toggle="yes">et al.</italic>, 2012</xref>), and the binding regions of ERα, FOXA1 and GATA3 is a breast cancer subtype-specific phenotypic feature (<xref rid="btac783-B6661385" ref-type="bibr">Fleischer, 2017</xref>). Cancer-specific differentially methylated CpG sites are enriched in known cancer genes and cell type-specific super-enhancers (SEs) (<xref rid="btac783-B60" ref-type="bibr">Yang <italic toggle="yes">et al.</italic>, 2017</xref>), comprising enhancer clusters in proximity (<xref rid="btac783-B25" ref-type="bibr">Hnisz <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btac783-B39" ref-type="bibr">Loven <italic toggle="yes">et al.</italic>, 2013</xref>). Moreover, methylation in the accessible chromatin defined by Assay for Transposase-Accessible Chromatin with high throughput sequencing (ATAC-seq) in primary human cancers was also reported to be involved in regulating distal target genes (<xref rid="btac783-B15" ref-type="bibr">Corces <italic toggle="yes">et al.</italic>, 2018</xref>; <xref rid="btac783-B33" ref-type="bibr">Lhoumaud <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btac783-B55" ref-type="bibr">Wang <italic toggle="yes">et al.</italic>, 2021</xref>). Meanwhile, the biophysical communication between genes and these regulatory elements could be explained using the 3D genome technique (<xref rid="btac783-B6" ref-type="bibr">Bonev and Cavalli, 2016</xref>; <xref rid="btac783-B17" ref-type="bibr">Dekker and Mirny, 2016</xref>; <xref rid="btac783-B47" ref-type="bibr">Rao <italic toggle="yes">et al.</italic>, 2014</xref>). In principle, the methylation status of cytosines on the ligated DNA is preserved in experiments on chromosome conformation capture (<xref rid="btac783-B34" ref-type="bibr">Li <italic toggle="yes">et al.</italic>, 2019</xref>). For an inferred CpG–target gene pair, mapping CpG and promoter simultaneously to 3D interaction anchors can help validate the pairs. Above all, annotating CpGs to these cell type-specific <italic toggle="yes">cis</italic>-regulatory elements and TF-binding sites (TFBS) helps explain target gene regulation based on DNA methylation in cancer.</p>
    <p>At present, some databases for DNA methylation have been built. For example, MethHC is an integrated and web-based resource focusing on the aberrant methylomes of human cancer (<xref rid="btac783-B28" ref-type="bibr">Huang <italic toggle="yes">et al.</italic>, 2015</xref>, <xref rid="btac783-B27" ref-type="bibr">2021</xref>). MethHC mainly provided aberrant DNA methylation in gene body, promoter and enhancer regions. MethMotif (<xref rid="btac783-B59" ref-type="bibr">Xuan Lin <italic toggle="yes">et al.</italic>, 2019</xref>) is a 2D TFBS database that records TFBS position weight matrices along with cell type-specific CpG methylation at TFBS. Other databases, such as MethyCancer (<xref rid="btac783-B24" ref-type="bibr">He <italic toggle="yes">et al.</italic>, 2008</xref>), MENT (<xref rid="btac783-B3" ref-type="bibr">Baek <italic toggle="yes">et al.</italic>, 2013</xref>), DiseaseMeth (<xref rid="btac783-B57" ref-type="bibr">Xiong <italic toggle="yes">et al.</italic>, 2017</xref>), DNMIV (<xref rid="btac783-B18" ref-type="bibr">Ding <italic toggle="yes">et al.</italic>, 2020</xref>), EWAS (<xref rid="btac783-B34" ref-type="bibr">Li <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btac783-B58" ref-type="bibr">Xiong <italic toggle="yes">et al.</italic>, 2020</xref>) and SurvivalMeth (<xref rid="btac783-B64" ref-type="bibr">Zhang <italic toggle="yes">et al.</italic>, 2021</xref>), have been developed for DNA methylation in diseases, especially cancer. These existing databases provide a resource for upstream <italic toggle="yes">cis</italic>-regulatory elements or TFBS information for CpGs or downstream annotations for target genes in different cells or diseases. They have become valuable resources for investigating DNA methylation. However, no existing databases comprehensively provide upstream and downstream annotations for CpG–gene pairs. In addition, the existing databases mainly focused on DNA methylation in gene promoter or body, ignoring distal <italic toggle="yes">cis</italic>-regulatory elements. Accumulating studies of DNA methylation within distinct distal <italic toggle="yes">cis</italic>-regulatory elements and the rapid accumulation of transcriptome and epigenomic profiles of human cancers have led to the urgent need to systematically collect the aforementioned <italic toggle="yes">cis</italic>-regulatory elements and TFs, besides integrating DNA methylation and gene expression profiles to explore DNA methylation regulation comprehensively.</p>
    <p>We developed a comprehensive DNA methylation database CanMethdb to annotate CpGs and their target genes in diverse cancers. CanMethdb provides upstream <italic toggle="yes">cis</italic>-regulatory elements, especially those involving distal regions to genes, and TFBS annotations for CpGs. The <italic toggle="yes">cis</italic>-regulatory element includes cancer type-specific typical enhancers, SEs, chromatin accessibility regions defined by ATAC-seq, 3D chromatin interaction anchors and CGI. TFBS annotations include cancer type-specific ChIP-seq peaks and TF motifs. Furthermore, CanMethdb provides downstream functional and prognostic annotations for target genes of CpGs, computed using two methods by integrating abundant DNA methylation and gene expression profiles in 33 human cancers. In addition, 3D chromatin interaction verification analyses help users investigate whether the pairs are supported by 3D chromatin interaction anchors. Moreover, CanMethdb provides regulatory subnetwork analysis. The regulatory subnetwork reflects the relationship among CpGs, <italic toggle="yes">cis</italic>-regulatory elements, TFs and target genes. CanMethdb is an integrated cancer DNA methylation database that provides abundant gene regulatory annotations based on DNA methylation in multiple cancer types. CanMethdb may help biologists to perform in-depth studies of DNA methylation regulation mechanisms.</p>
  </sec>
  <sec>
    <title>2 Data source and method</title>
    <p>Our work was conducted with hg19 as the reference genome.</p>
    <sec>
      <title>2.1 Data source</title>
      <sec>
        <label>2.1.1</label>
        <title>Methylation and RNA-seq profiles</title>
        <p>CanMethdb integrated DNA methylation (Illumina HumanMethylation450, 450K) profiles and FPKM upper quartile RNA-seq profiles for protein-coding genes of 33 The Cancer Genome Atlas (TCGA) (<xref rid="btac783-B54" ref-type="bibr">Tomczak <italic toggle="yes">et al.</italic>, 2015</xref>) cancer types to get CpG–target gene pairs. For RNA-seq profiles, gene ID conversion from the ensembl format to gene symbols for protein-coding genes was done according to GENCODE (<xref rid="btac783-B23" ref-type="bibr">Harrow <italic toggle="yes">et al.</italic>, 2012</xref>). For 450K probes, we screened CpGs in 22 autosomal chromosomes. For each DNA methylation profile, CpGs with a missing value (‘NA’) ratio of more than 10% were discarded. For the remaining CpGs, the missing values were imputed with the mean <italic toggle="yes">β</italic> values of samples in the same type (cancer or normal) (<xref rid="btac783-B16" ref-type="bibr">Dahlin <italic toggle="yes">et al.</italic>, 2016</xref>). For each gene expression profile, low-expression genes (FPKM = 0 for &gt;10% of patients) were removed to ensure the reliability of the gene sets (<xref rid="btac783-B32" ref-type="bibr">Lee <italic toggle="yes">et al.</italic>, 2020</xref>). For each cancer type, only samples having both methylation and gene expression profiles were used to determine the target genes of CpGs.</p>
      </sec>
      <sec>
        <label>2.1.2</label>
        <title><italic toggle="yes">Ci</italic>s-regulatory elements</title>
        <p>We collected and integrated five kinds of <italic toggle="yes">cis</italic>-regulatory elements to annotate DNA methylation: typical enhancers, SEs, ATAC-seq regions, 3D chromatin interaction anchors and CGI (<xref rid="btac783-T1" ref-type="table">Table 1</xref>). Typical enhancers in CanMethdb were downloaded from Fantom5 Transcribed Enhancer Atlas (<xref rid="btac783-B1" ref-type="bibr">Andersson <italic toggle="yes">et al.</italic>, 2014</xref>), a database describing enhancer regions defined using Cap Analysis of Gene Expression tags, encompassing 808 human samples, from which we manually annotated and screened 208 cancer cell line samples (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). SEs in CanMethdb were obtained from SEdb (<xref rid="btac783-B29" ref-type="bibr">Jiang <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btac783-B44" ref-type="bibr">Qian <italic toggle="yes">et al.</italic>, 2019</xref>) developed by our group using ROSE (<xref rid="btac783-B39" ref-type="bibr">Loven <italic toggle="yes">et al.</italic>, 2013</xref>) from 542 manually collected human public H3K27ac samples, from which we manually annotated and screened 315 cancer samples (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>). The merged cancer type-specific ATAC regions were downloaded from a paper generating high-quality ATAC-seq data in 410 TCGA tumor samples across 23 cancer types (<xref rid="btac783-B15" ref-type="bibr">Corces <italic toggle="yes">et al.</italic>, 2018</xref>). We integrated the chromatin interaction datasets of 234 samples from 4Dgenome (<xref rid="btac783-B52" ref-type="bibr">Teng <italic toggle="yes">et al.</italic>, 2016</xref>), Oncobase (<xref rid="btac783-B34" ref-type="bibr">Li <italic toggle="yes">et al.</italic>, 2019</xref>), The 3D Genome Browser (<xref rid="btac783-B56" ref-type="bibr">Wang <italic toggle="yes">et al.</italic>, 2018</xref>) and NCBI (<xref rid="btac783-B5" ref-type="bibr">Barrett <italic toggle="yes">et al.</italic>, 2013</xref>), including 41 cancer samples (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>). CGI was downloaded from UCSC (<xref rid="btac783-B22" ref-type="bibr">Haeussler <italic toggle="yes">et al.</italic>, 2019</xref>), involving 28 691 CGIs. CGI in CanMethdb had no distinction between diseases. SE samples covered 17 out of the 33 target gene cancer types (17/33), typical enhancers covered 25/33, ATAC-seq regions covered 23/33 and 3D chromatin interaction regions covered 12/33.</p>
        <table-wrap position="float" id="btac783-T1">
          <label>Table 1.</label>
          <caption>
            <p>Statistics of <italic toggle="yes">cis</italic>-regulatory elements and TFBS sources</p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col valign="top" align="left" span="1"/>
              <col valign="top" align="left" span="1"/>
              <col valign="top" align="char" char="." span="1"/>
              <col valign="top" align="left" span="1"/>
              <col valign="top" align="char" char="." span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th rowspan="1" colspan="1"><italic toggle="yes">Cis</italic>-regulatory elements and TFs</th>
                <th rowspan="1" colspan="1">Sources</th>
                <th rowspan="1" colspan="1">Number of all cancer samples<xref rid="tblfn1" ref-type="table-fn"><sup>a</sup></xref></th>
                <th rowspan="1" colspan="1">Average number</th>
                <th rowspan="1" colspan="1">Num. of TCGA cancer types</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">Typical enhancer</td>
                <td rowspan="1" colspan="1">Fantom5</td>
                <td rowspan="1" colspan="1">208</td>
                <td rowspan="1" colspan="1">∼620 per sample</td>
                <td rowspan="1" colspan="1">25</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Super-enhancer</td>
                <td rowspan="1" colspan="1">SEdb</td>
                <td rowspan="1" colspan="1">315</td>
                <td rowspan="1" colspan="1">∼500 per sample</td>
                <td rowspan="1" colspan="1">17</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">ATAC-seq regions</td>
                <td rowspan="1" colspan="1">Corces <italic toggle="yes">et al.</italic> (2018)</td>
                <td rowspan="1" colspan="1">410</td>
                <td rowspan="1" colspan="1">∼105 585 per cancer type</td>
                <td rowspan="1" colspan="1">23</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">3D chromatin interaction</td>
                <td rowspan="1" colspan="1">4DGenome<break/>Oncobase<break/>The 3D Genome Browser<break/>NCBI</td>
                <td rowspan="1" colspan="1">41</td>
                <td rowspan="1" colspan="1">∼74 392 per cell line</td>
                <td rowspan="1" colspan="1">12</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">CGI</td>
                <td rowspan="1" colspan="1">UCSC</td>
                <td rowspan="1" colspan="1">–</td>
                <td rowspan="1" colspan="1">28 691</td>
                <td rowspan="1" colspan="1">–</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">TF by ChIP-seq</td>
                <td rowspan="1" colspan="1">ENCODE<break/>Remap<break/>Cistrome<break/>ChIP-Atlas<break/>GTRD</td>
                <td rowspan="1" colspan="1">1853</td>
                <td rowspan="1" colspan="1">645 unique TFs</td>
                <td rowspan="1" colspan="1">23</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">TF by motif</td>
                <td rowspan="1" colspan="1">TRANSFAC<break/>MEME</td>
                <td rowspan="1" colspan="1">–</td>
                <td rowspan="1" colspan="1">More than 3000 motifs for ∼700 TFs</td>
                <td rowspan="1" colspan="1">–</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="tblfn1">
              <label>a</label>
              <p>Number of all cancer samples: the number of total cancer samples, including TCGA and non-TCGA cancer types.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <label>2.1.3</label>
        <title>TF ChIP-seq peaks and motifs</title>
        <p>We mapped CpGs to TFs based on ChIP-seq and motifs (<xref rid="btac783-T1" ref-type="table">Table 1</xref>). We manually screened 1853 cancer samples with TF ChIP-seq peaks (<xref rid="btac783-T1" ref-type="table">Table 1</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S4</xref>) from ENCODE (<xref rid="btac783-B14" ref-type="bibr">The ENCODE Project Consortium, 2012</xref>), Remap (<xref rid="btac783-B11" ref-type="bibr">Cheneby <italic toggle="yes">et al.</italic>, 2018</xref>), Cistrome (<xref rid="btac783-B42" ref-type="bibr">Mei <italic toggle="yes">et al.</italic>, 2017</xref>), ChIP-Atlas (<xref rid="btac783-B43" ref-type="bibr">Oki <italic toggle="yes">et al.</italic>, 2018</xref>) and GTRD (<xref rid="btac783-B62" ref-type="bibr">Yevshin <italic toggle="yes">et al.</italic>, 2017</xref>). ChIP-seq peaks covered 23 out of the 33 target gene cancer types. We compiled 3000 DNA-binding motifs for ∼700 TFs, from TRANSFAC (<xref rid="btac783-B40" ref-type="bibr">Matys <italic toggle="yes">et al.</italic>, 2006</xref>) and Multiple Em for Motif Elicitation (MEME) suites (<xref rid="btac783-B4" ref-type="bibr">Bailey <italic toggle="yes">et al.</italic>, 2009</xref>; <xref rid="btac783-B49" ref-type="bibr">Saint-Andre <italic toggle="yes">et al.</italic>, 2016</xref>). TFs by motif annotations for the CpGs in CanMethdb had no distinction between diseases.</p>
      </sec>
    </sec>
    <sec>
      <title>2.2 Method</title>
      <sec>
        <label>2.2.1</label>
        <title>Inferring target genes for CpGs</title>
        <p>We considered 20 nearby protein-coding genes (10 on each side) of the CpGs as the candidate set, which is recommended by the ELMER method (<xref rid="btac783-B61" ref-type="bibr">Yao <italic toggle="yes">et al.</italic>, 2015</xref>), one of the two methods we used to calculate the target genes for CpGs. ELMER have revealed regulatory roles for CpGs in enhancers, indicating the effect of DNA methylation on gene expressions can depend strongly on the genomic location of the CpG, and have been widely used to infer enhancer-target genes based on DNA methylation (<xref rid="btac783-B38" ref-type="bibr">Liu <italic toggle="yes">et al.</italic>, 2021</xref>; <xref rid="btac783-B45" ref-type="bibr">Qin <italic toggle="yes">et al.</italic>, 2022</xref>; <xref rid="btac783-B65" ref-type="bibr">Zhao <italic toggle="yes">et al.</italic>, 2021</xref>). If the gene number on one side was &lt;10, then genes on the other side were used to replenish. The distance distribution statistics between CpGs to their 20 nearby genes showed that most of them (&gt;90%) were located within 2 Mb of the CpGs (see details in the added ‘Statistics’ page on the website). To the best of our knowledge, this distance could cover promoter regions and most of the distal regulatory elements of genes (<xref rid="btac783-B12" ref-type="bibr">Chepelev <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btac783-B15" ref-type="bibr">Corces <italic toggle="yes">et al.</italic>, 2018</xref>; <xref rid="btac783-B25" ref-type="bibr">Hnisz <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btac783-B37" ref-type="bibr">Lieberman-Aiden <italic toggle="yes">et al.</italic>, 2009</xref>). Of the nearby 20 genes, whose expressions negatively correlated with the CpG methylation levels, were predicted as target genes. The genomic location annotation files of Illumina HumanMethylation450 BeadChip (450K, GPL13534) were downloaded from the GEO database (<xref rid="btac783-B5" ref-type="bibr">Barrett <italic toggle="yes">et al.</italic>, 2013</xref>), and probes on X and Y chromosome and single nucleotide polymorphism sites (ID start with ‘rs’) were removed; finally, 473 864 CpG probes remained. The gene TSS used here was extracted from the genome annotation file (hg19) in the GENCODE database (<xref rid="btac783-B23" ref-type="bibr">Harrow <italic toggle="yes">et al.</italic>, 2012</xref>).</p>
        <p>Pearson’s correlation coefficient based on Python and R-based ELMER (<xref rid="btac783-B61" ref-type="bibr">Yao <italic toggle="yes">et al.</italic>, 2015</xref>) was used to determine target genes with CpG methylation and RNA-seq profiles. In each cancer type, we identified target genes from the candidate gene set for each CpG. For a candidate gene, if it was a target gene of a CpG with either one of the two methods, then it was stored as a target gene in CanMethdb. Pearson correlation coefficient in CanMethdb was implemented using Python with scipy.stats.pearsonr (Pearson’s correlation coefficient &lt;0, Pearson’s <italic toggle="yes">P</italic>-value ≤0.05). ELMER is a bioinformatics tool that correlates the enhancer state with the expression of nearby genes based on methylation to identify transcriptional targets in cancer (<xref rid="btac783-B61" ref-type="bibr">Yao <italic toggle="yes">et al.</italic>, 2015</xref>). It uses a non-parametric <italic toggle="yes">U</italic>- test, namely the Wilcoxon test, to compare methylation quintiles versus the expression to determine the target genes of CpGs. For a CpG in one cancer type, ELMER ranked samples according to the CpG <italic toggle="yes">β</italic> values. Subsequently, the samples were assorted into two groups to screen target genes: the most unmethylated and the most methylated (we used the default 20%) to test whether the gene expression level of the former was greater than the level of the latter using the Wilcoxon test (<italic toggle="yes">P</italic>-value ≤0.05).</p>
        <p>After computing, a total of 38 986 060 CpG–target gene pairs (ranging from 269 903 to 2 053 444 in different cancers) in 33 TCGA cancer types, were obtained. There were common pairs among different cancer types and 6 769 130 pairs were unique, involving 385 217 CpGs and 18 044 target genes.</p>
        <p>Because recent studies showed that CpG methylation could also be positively related to target gene expression (Shin <italic toggle="yes">et al.</italic>, 2022), we also provided CpG–gene pairs with positive correlations (Pearson’s correlation coefficient &gt;0, Pearson’s <italic toggle="yes">P</italic>-value ≤0.05). If users want to view positive pairs for different cancer types, they can obtain them from the download page of the database.</p>
      </sec>
      <sec>
        <label>2.2.2</label>
        <title>Annotating CpGs to <italic toggle="yes">cis</italic>-regulatory elements and TFs</title>
        <p>CpGs involved in CpG–target gene pairs were annotated to the aforementioned distinct <italic toggle="yes">cis</italic>-regulatory elements and TF ChIP-seq peaks in matched/all cancer types with bedtools (<xref rid="btac783-B46" ref-type="bibr">Quinlan and Hall, 2010</xref>). The genomic location version used here was hg19.</p>
        <p>TF motif occurrences at CpG sites were measured against 21 bp sequences composed of cytosine and its nearby 20 bases (10 on each side), using Find Individual Motif Occurrence (<xref rid="btac783-B21" ref-type="bibr">Grant <italic toggle="yes">et al.</italic>, 2011</xref>) from the MEME suite (<xref rid="btac783-B4" ref-type="bibr">Bailey <italic toggle="yes">et al.</italic>, 2009</xref>). Finally, more than 160 000 CpGs were inferred to be bound by ∼300 TFs with a <italic toggle="yes">q</italic>-value threshold of 1e–3.</p>
        <p>As a result, 229 699 out of the total 473 864 CpGs were mapped to SEs; 6167 to fantom5 enhancers; 84 410 to ATAC-seq regions; 388 626 to TFs by ChIP-seq; 374 660 to TFs by motif; 412 283 to chromatin interaction regions and 145 842 to CGIs.</p>
      </sec>
      <sec>
        <label>2.2.3</label>
        <title>Sequence conservation</title>
        <p>We obtained phyloP46way scores from multiple alignments of 46 mammal genomes from the UCSC browser to measure the conservation of each CpG.</p>
      </sec>
      <sec>
        <label>2.2.4</label>
        <title>Differentially methylated CpGs</title>
        <p>Limma is a widely used package, designed for differential expression analysis of data arising from microarray experiments (<xref rid="btac783-B51" ref-type="bibr">Smyth, 2005</xref>). It provides an integrated data analysis solution, using advanced computational algorithms to deliver reliable performance on large datasets and powers differential expression analyses for RNA-sequencing and microarray studies (<xref rid="btac783-B48" ref-type="bibr">Ritchie <italic toggle="yes">et al.</italic>, 2015</xref>). We used the Bioconductor package ‘limma’ (Release 3.7) to calculate differentially methylated CpGs between tumor and normal samples with the false discovery rate ≤0.05 and the difference of mean DNA methylation level between normal and tumor samples ≥0.1. If the methylation level of a CpG was higher in tumor samples than that in normal samples, we defined it as hypermethylated one, otherwise hypomethylated one (<xref rid="btac783-B60" ref-type="bibr">Yang <italic toggle="yes">et al.</italic>, 2017</xref>).</p>
        <p>We used this method to define methylation status for the paired CpGs in 20 cancer types (the other 13 cancer types lacked normal samples). Finally, we found that an average of 35 105 CpGs in each cancer type (ranging from 4540 to 48 597) was hypermethylated and 43 638 (ranging from 10 186 to 88 680 in different cancers) were hypomethylated.</p>
      </sec>
    </sec>
  </sec>
  <sec>
    <title>3 Database use and access</title>
    <sec>
      <title>3.1 Overview of CanMethdb</title>
      <p>The main elements of CanMethdb, including data source and database use, are shown in <xref rid="btac783-F1" ref-type="fig">Figure 1</xref>.</p>
      <fig position="float" id="btac783-F1">
        <label>Fig. 1.</label>
        <caption>
          <p>Database content and construction. CanMethdb contains abundant upstream and downstream annotations for genome-wide CpG–target gene pairs in diverse cancer types. CanMethdb provides a user-friendly interface to query, browse, analyze, visualize and download detailed information about these annotations</p>
        </caption>
        <graphic xlink:href="btac783f1" position="float"/>
      </fig>
      <p>The current version of CanMethdb contains abundant annotations for genome-wide CpG–target gene pairs, including upstream <italic toggle="yes">cis</italic>-regulatory elements and TFBS annotations for the CpGs and downstream annotations for the target genes in 33 TCGA cancer types (<xref rid="btac783-F1" ref-type="fig">Fig. 1</xref>). Especially, the correlations of the pairs are visualized using scatter plots, and the global correlation between the CpG and 20 nearby genes is also visible. In addition, 3D chromatin interaction verification analyses are provided to validate the pairs by mapping CpG and promoter simultaneously to 3D interaction anchors. Moreover, CanMethdb provides regulatory subnetwork analysis. Users can submit a genomic region list, TFs, CpGs or genes to extract the subnetwork (composed of input nodes and their one-step neighbors) from the CpGs to target genes, TFs and <italic toggle="yes">cis</italic>-regulatory elements background network. CanMethdb provides a user-friendly interface to query, analyze, browse, download and visualize detailed information about CpG–target gene pairs.</p>
    </sec>
    <sec>
      <title>3.2 A Search interface for retrieving CpG–target gene pairs in different cancer types</title>
      <p>CanMethdb provides four kinds of inquiry paths to get annotations of CpG–target gene (<xref rid="btac783-F2" ref-type="fig">Fig. 2A</xref>). In ‘Search by genomic region’, in a cancer type, users can either input a genomic region or select one or more of the following seven categories of CpG annotation information: SE, enhancer, ATAC-seq regions, 3D chromatin interaction regions, CGI, TFs by ChIP-seq and TFs by the motif. In ‘Search by CpG’, users should input a CpG in 450K CpG name format. In ‘Search by gene name’, users can input a gene name to get paired CpGs. In ‘Search by disease’, users can select ‘hyper’ or ‘hypo’ to get all hyper- or hypomethylated CpGs of the selected cancer type. The information on the search results is displayed mainly in a table on the result page (<xref rid="btac783-F2" ref-type="fig">Fig. 2A</xref>). Each row in the table describes a related CpG, target genes for the CpG in selected cancer type and all <italic toggle="yes">cis</italic>-regulatory elements and TFs annotated to the CpG in cancers. The search result page also provides basic information for the cancer type chosen and statistics of the cancer sample number of <italic toggle="yes">cis</italic>-regulatory elements and TF ChIP-seq.</p>
      <fig position="float" id="btac783-F2">
        <label>Fig. 2.</label>
        <caption>
          <p>Main functions and usage of CanMethdb. (<bold>A</bold>) Four inquiry modes and search results including statistics of annotations for related CpGs, basic information of chosen cancer types and the number of cancer samples of <italic toggle="yes">cis</italic>-regulatory elements and TFs for cancer samples. (<bold>B</bold>) Details about upstream and downstream annotations for a CpG and its target genes. (<bold>C</bold>) Three online tools to interactively analyze the gene regulation, including ‘3D validation analysis’, ‘Pathway enrichment analysis’ and ‘Regulatory subnetwork analysis’. (<bold>D</bold>) Browsing details of CpG–target gene pairs in 33 cancers. (<bold>E</bold>) Genome browser to visualize the upstream <italic toggle="yes">cis</italic>-regulatory elements and TFs for CpGs and genes</p>
        </caption>
        <graphic xlink:href="btac783f2" position="float"/>
      </fig>
      <p>Users can view detailed information for each CpG and its target genes on a new page by clicking ‘detail’ at the end of each row. The detailed information is listed below (<xref rid="btac783-F2" ref-type="fig">Fig. 2B</xref>): (i) general information of the CpG. Basic information for the CpG, such as location, differences of methylation status between cancer and normal samples and conservation, is provided. (ii) Regulation visualization of the CpG. Users can intuitively visualize the global relationships between CpG and its surrounding 20 genes. The association degree between the CpG methylation level and target gene expression is shown by the line thickness. Besides, regulatory network provides an overview of the relationships between the CpG and its target genes, annotated <italic toggle="yes">cis</italic>-regulatory elements and TFs in cancers. (iii) Target genes information of the CpG. Users can view detailed information on the expression and survival of each target gene of the CpG. This includes a scatter plot to show the correlation between the CpG methylation levels and each target gene expression status, the expression patterns of target genes in 33 cancer types, and the expression pattern and survival analysis in selected cancer types. Besides, users can also click the gene name hyperlink to view all related CpGs of the gene in turn. (iv) CpG annotating information. Detailed mapping information for the CpG to <italic toggle="yes">cis</italic>-regulatory elements and TFs is provided in this section. Users can switch to the component of interest to view detailed information. Specifically, for typical enhancers, SE, ATAC-seq regions, 3D chromatin interaction anchors and TFs by ChIP-seq, users can choose only to view them in target gene matched cancer type or in all cancer samples by clicking the radio button.</p>
    </sec>
    <sec>
      <title>3.3 Online analysis tools</title>
      <p>CanMethdb provides the following three analyses to interactively analyze the gene regulation based on methylation (<xref rid="btac783-F2" ref-type="fig">Fig. 2C</xref>): (i) 3D validation analysis. Users input CpGs or gene names directly to explore whether 3D chromatin interaction anchors support related CpG–target gene pairs in CanMethdb in different tissues. The input can also be genomic regions. Then, CpGs in these regions are explored. The related CpG–target gene pairs of inputs are analyzed using bedtools (<xref rid="btac783-B46" ref-type="bibr">Quinlan and Hall, 2010</xref>). The CpGs and gene promoters in pairs are analyzed separately against two anchors of all 3D chromatin interactions in the selected tissue. As a result, only the pairs with at least one end overlapping with an anchor are displayed. (ii) Pathway enrichment analysis. CanMethdb integrated 2880 pathways from 10 pathway databases: KEGG, Reactome, NetPath, WikiPathways, PANTHER, PID, Hu-manCyc, CTD, SMPDB and INOH (<xref rid="btac783-B8" ref-type="bibr">Cerami <italic toggle="yes">et al.</italic>, 2011</xref>; <xref rid="btac783-B30" ref-type="bibr">Kanehisa <italic toggle="yes">et al.</italic>, 2016</xref>). Users input CpG sets and select target gene cutoffs to perform pathway enrichment analysis with target genes. The output table contains CpG–target gene pairs. (iii) Regulatory subnetwork analysis. The components of the regulatory network include CpGs, cancer-specific target genes, SE, typical enhancers, ATAC regions, 3D chromatin interaction regions and TFs by CHIP-seq, as well as CGI and TFs by motif. The edges in the network link CpGs to other nodes. Users select a cancer type and input node names or regions. The node names can be any one or more of TFs, gene names or CpGs. If users input TFs, the mapped CpGs by ChIP-seq and motifs are shown on the results page. If users input gene names directly, the cutoff of target gene prediction could be set by users, and then paired CpGs are shown in the result. If users input CpGs, the target genes and mapped <italic toggle="yes">cis</italic>-regulatory elements and TFs would be shown. If users input regions, five kinds of regulatory elements (SEs, enhancers, chromatin accessibility regions and 3D chromatin interaction regions of the current cancer type as well as CGIs overlapping with the inputs) are shown. In addition, CpGs located in these elements and their target genes are also shown on the result page.</p>
    </sec>
    <sec>
      <title>3.4 User-friendly browsing</title>
      <p>This page is organized as an interactive table that allows users to quickly search for interested CpG–target gene pairs according to ‘chromosome’ and ‘cancer type’ and hence browse all CpG–target gene pairs more conveniently (<xref rid="btac783-F2" ref-type="fig">Fig. 2D</xref>).</p>
    </sec>
    <sec>
      <title>3.5 Data visualization</title>
      <p>We developed a personalized genome browser with jBrowse to help users view transcriptional regulatory information of genes across the genome comprehensively and intuitively. TFs by ChIP-seq tracks and <italic toggle="yes">cis</italic>-regulatory element tracks, including typical enhancers, SE and ATAC-seq regions, were arranged by cancer type (<xref rid="btac783-F2" ref-type="fig">Fig. 2E</xref>). CpG and gene tracks were also supported at the same time. Users could view regulatory information around a CpG, gene or genomic region of interest via data visualization.</p>
    </sec>
    <sec>
      <title>3.6 Data download</title>
      <p>All CpG–target gene pairs, including the negatively and positively correlated pairs, and CpGs mapping to five kinds of <italic toggle="yes">cis</italic>-regulatory elements and two kinds of TFs are provided on the ‘Download’ page. In addition, CanMethdb supported the export of query results on each search result page.</p>
    </sec>
    <sec>
      <title>3.7 Case study</title>
      <p>We searched the database with a reported CpG–target gene pair cg19942083–PTPN6 to illustrate the usage of CanMethdb by inputting the CpG name, CpG location or the gene name. The methylation of cg19942083, located in the intergenic region, was associated with kidney function and lower renal PTPN6 expression (<xref rid="btac783-B13" ref-type="bibr">Chu <italic toggle="yes">et al.</italic>, 2017</xref>). We inquired this pair in CanMethdb and found that PTPN6 was a target gene of cg19942083 in kidney cancer, which was consistent with the previous report. CanMethdb stored information on three types of kidney cancer, including kidney chromophobe, kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma. Taking KIRC as a case, we retrieved more annotations for this pair in CanMethdb. We found that the hypomethylation of cg19942083, located within the SE region, might recruit TFs, such as FOXA1, MYC and EGR1, to the CpG site and lead to the overexpression of PTPN6 through interacting with its promoter.</p>
      <p>In detail, first, PTPN6 was significantly targeted by cg19942083 (Pearson’s correlation coefficient =–2.8, Pearson’s <italic toggle="yes">P</italic>-value =2.28E-8; ELMER’s <italic toggle="yes">P</italic>-value = 7.3E-8) in KIRC (<xref rid="btac783-F3" ref-type="fig">Fig. 3B</xref>), where cg19942083 was significantly hypomethylated (<xref rid="btac783-F3" ref-type="fig">Fig. 3A</xref>) and PTPN6 was overexpressed (<xref rid="btac783-F3" ref-type="fig">Fig. 3B</xref>). The general and regulation visualization information for CpG showed that cg19942083 was located distal to PTPN6 (∼4.9 kb downstream from the TSS of PTPN6) (<xref rid="btac783-F3" ref-type="fig">Fig. 3A</xref>). Moreover, the upstream annotation for the CpG showed that cg19942083 was located within SE regions and bound by multiple TFs, such as FOXA1 and EGR1, in cancer samples (<xref rid="btac783-F3" ref-type="fig">Fig. 3C</xref>). In addition, the downstream annotation for the target gene showed that PTPN6 was associated with the prognosis of KIRC and was also overexpressed in most other cancer types (<xref rid="btac783-F3" ref-type="fig">Fig. 3B</xref>). Interestingly, the 3D chromatin interaction validation analysis showed that the pair cg19942083-PTPN6 was located in a 3D chromatin interaction loop in kidney tissues (<xref rid="btac783-F3" ref-type="fig">Fig. 3D</xref>). Furthermore, studies showed that PTPN6 was a cancer marker gene closely related to DNA methylation. These results prompted that the DNA methylation of distal <italic toggle="yes">cis</italic>-regulatory elements might play an important role in the dysregulation of target PTPN6 expression through TF binding and biophysical communication in KIRC. Thus, we concluded that CanMethdb was a valuable platform for performing in-depth research and revealing DNA methylation regulation mechanisms in cancer.</p>
      <fig position="float" id="btac783-F3">
        <label>Fig. 3.</label>
        <caption>
          <p>Case study with cg19942083–PTPN6 pair reported in kidney. (<bold>A</bold>) PTPN6 was significantly targeted by cg19942083 in KIRC and cg19942083 was located distal to PTPN6. (<bold>B</bold>) PTPN6 was associated with the prognosis of KIRC and was overexpressed in most cancers including KIRC. (<bold>C</bold>) The cg19942083 was located within SE regions and bound by multiple TFs, such as FOXA1 and EGR1, in cancers. (<bold>D</bold>) The 3D chromatin interaction validation analysis showed that the pair cg19942083–PTPN6 was located in a 3D chromatin interaction loop in kidney tissues</p>
        </caption>
        <graphic xlink:href="btac783f3" position="float"/>
      </fig>
    </sec>
    <sec>
      <title>3.8 Availability</title>
      <p>The core codes, we have used to generate CpG–gene pairs and differentially methylated CpGs are freely available in the GitHub repository (<ext-link xlink:href="https://github.com/chunquanlipathway/CanMethdb" ext-link-type="uri">https://github.com/chunquanlipathway/CanMethdb</ext-link>). To allow researchers programmatically query and analyze CpG–target gene pairs in CanMethdb, we provided web APIs interfaces. CanMethdb APIs are protocols that allow researchers to query a CanMethdb data resource in the RESTful API format. We have added an ‘API’ page in the website, where we provided seven API interfaces, including four query and three analysis interfaces, as well as detailed parameter descriptions.</p>
    </sec>
  </sec>
  <sec>
    <title>4 Discussion</title>
    <p>The emerging importance of DNA methylation in upstream <italic toggle="yes">cis</italic>-regulatory elements and TFs increases the need for comprehensively understanding DNA methylation regulation in human cancers. In general, methylation is considered to regulate the activation of distinct regulatory elements by reducing accessibility and TF binding. Some databases, such as MethyCancer (23), MENT (24), DNMIV (26), EWAS (27, 28), MethHC (<xref rid="btac783-B28" ref-type="bibr">Huang <italic toggle="yes">et al.</italic>, 2015</xref>, <xref rid="btac783-B27" ref-type="bibr">2021</xref>) and SurvivalMeth (29), have been developed for DNA methylation. These databases provide a resource for upstream or downstream annotations for DNA methylations and target genes in different cells or diseases and have become valuable resources for investigating DNA methylation. However, no existing databases comprehensively provide upstream and downstream annotations for CpG–gene pairs in cancers and they mainly focused on DNA methylations in gene promoter or body, ignoring distal <italic toggle="yes">cis</italic>-regulatory element (<xref rid="btac783-T2" ref-type="table">Table 2</xref>). In recent years, an increasing number of studies have focused on DNA methylation located in distal regulatory elements, away from gene promoter and body in cancers. The increasing studies of DNA methylation within distinct distal <italic toggle="yes">cis</italic>-regulatory elements as well as the rapid accumulation of transcriptome and epigenomic profiles of human cancers have led to the urgent need to systematically collect distinct <italic toggle="yes">cis</italic>-regulatory elements involving distal regions and TFs, besides integrating methylome and transcriptome profiles to explore DNA methylation regulation comprehensively. We developed CanMethdb, which focused on providing comprehensively distinct upstream regulatory elements, especially those involving regions distal to genes and TF annotations for DNA methylation and downstream target genes of DNA methylation as well as related annotations in diverse cancers.</p>
    <table-wrap position="float" id="btac783-T2">
      <label>Table 2.</label>
      <caption>
        <p>Comparison of information in CanMethdb with other databases</p>
      </caption>
      <table frame="hsides" rules="groups">
        <colgroup span="1">
          <col valign="top" align="left" span="1"/>
          <col valign="top" align="center" span="1"/>
          <col valign="top" align="center" span="1"/>
          <col valign="top" align="center" span="1"/>
          <col valign="top" align="center" span="1"/>
          <col valign="top" align="center" span="1"/>
          <col valign="top" align="center" span="1"/>
          <col valign="top" align="center" span="1"/>
        </colgroup>
        <thead>
          <tr>
            <th rowspan="1" colspan="1">Item</th>
            <th rowspan="1" colspan="1">CanMethdb</th>
            <th rowspan="1" colspan="1">SurvivalMeth</th>
            <th rowspan="1" colspan="1">DNMIVD</th>
            <th rowspan="1" colspan="1">EWAS</th>
            <th rowspan="1" colspan="1">MethHC2.0</th>
            <th rowspan="1" colspan="1">MENT</th>
            <th rowspan="1" colspan="1">MethyCancer</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">Distal elements</td>
            <td rowspan="1" colspan="1">4<xref rid="tblfn2" ref-type="table-fn"><sup>a</sup></xref></td>
            <td rowspan="1" colspan="1">1</td>
            <td rowspan="1" colspan="1">1</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">1</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">TFs to CpGs by ChIP-seq</td>
            <td rowspan="1" colspan="1">√</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">TFs to CpGs by motif</td>
            <td rowspan="1" colspan="1">√</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CpG–gene pair sources</td>
            <td rowspan="1" colspan="1">2<xref rid="tblfn3" ref-type="table-fn"><sup>b</sup></xref></td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">1</td>
            <td rowspan="1" colspan="1">Unknown</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">1</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">3D validations</td>
            <td rowspan="1" colspan="1">√</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Subnetwork analysis</td>
            <td rowspan="1" colspan="1">√</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">–</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Pathway sources</td>
            <td rowspan="1" colspan="1">10<xref rid="tblfn4" ref-type="table-fn"><sup>c</sup></xref></td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">1</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">1</td>
            <td rowspan="1" colspan="1">–</td>
            <td rowspan="1" colspan="1">Unknown</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Number of cancers</td>
            <td rowspan="1" colspan="1">33</td>
            <td rowspan="1" colspan="1">36</td>
            <td rowspan="1" colspan="1">26</td>
            <td rowspan="1" colspan="1">39</td>
            <td rowspan="1" colspan="1">33</td>
            <td rowspan="1" colspan="1">30</td>
            <td rowspan="1" colspan="1">10</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Number of target genes for CpGs</td>
            <td rowspan="1" colspan="1">18 044</td>
            <td rowspan="1" colspan="1">∼20 000</td>
            <td rowspan="1" colspan="1">20 141</td>
            <td rowspan="1" colspan="1">36 397</td>
            <td rowspan="1" colspan="1">28 047</td>
            <td rowspan="1" colspan="1">15 284</td>
            <td rowspan="1" colspan="1">7100</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tblfn2">
          <label>a</label>
          <p><italic toggle="yes">Cis</italic>-regulatory elements involving regions distal to genes include super-enhancer, enhancer, ATAC-seq regions and 3D chromatin interaction archors.</p>
        </fn>
        <fn id="tblfn3">
          <label>b</label>
          <p>CpG–gene pair sources were computed from Pearson correlation and Wilcoxon test.</p>
        </fn>
        <fn id="tblfn4">
          <label>c</label>
          <p>Pathway were collected from 10 resources: KEGG, Reactome, PANTHER, SMPDB, NetPath, PID, HumanCyc, CTD, WikiPathways and INOH.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>CanMethdb supported a user-friendly interface to query, analyze, browse, visualize and download detailed information on DNA methylation regulation. The main advantages of CanMethdb were as follows: (i) it provided distinct upstream annotations for CpGs, including cancer type-specific <italic toggle="yes">cis</italic>-regulatory elements, TFs and CGI. (ii) It provided CpG–target gene pairs, computed by two methods through integrating abundant DNA methylation and gene expression profiles in 33 human cancers. Especially, the correlations of the pairs were visualized using a scatter plot; the global correlations between the CpG and the 20 nearby genes were also visible. In addition, 3D chromatin interaction verification analyses were provided to validate the pairs by mapping CpG and promoter simultaneously to 3D interaction anchors. (iii) It provided expression patterns survival and pathway annotations for downstream target genes of CpGs. (iv) It provided regulatory subnetwork analysis. Users could submit a genomic region list, TFs, CpGs, or genes to extract subnetwork (composed of input nodes and their one-step neighbors) from the CpGs to target genes, TFs by ChIP-seq, TFs by motif, SE, enhancers, ATAC-seq regions, 3D chromatin interaction regions and CGI background network. The regulatory subnetwork reflected the relationship among <italic toggle="yes">cis</italic>-regulatory elements, TFs, CpGs and genes. (v) It provided four user-friendly ways to retrieve CpG–target gene pairs, including ‘by genomic region’, ‘by CpG’, ‘by gene name’ and ‘by disease’. (vi) Users could browse and download all CpG–target gene pairs as well as CpGs to distinct <italic toggle="yes">cis</italic>-elements and TF pairs in CanMethdb. (vii) Users could view regulatory information around a CpG, gene or a functional region of interest in a specified cancer type via data visualization.</p>
    <p>The fields of epigenome and transcriptome analyses have developed rapidly and become highly investigated areas. CanMethdb is a novel DNA methylation database comprising a systematic integration of abundant <italic toggle="yes">cis</italic>-regulatory elements, especially those involving distal regions to genes, and TFBS, in addition to a large number of DNA methylation and gene expression profiles to comprehensively annotate genome-wide CpG–target gene pairs in cancers. Our efforts to establish this database were prompted by the need for researchers to understand the functions of methylations, especially methylation sites falling within distal regulatory elements and TFBS in cancers. These researchers include cell/molecular biologists, geneticists and data scientists. CanMethdb can help to understand the mechanism of gene regulation and the pathology of cancers, even in biological and clinical studies. For example, DNA methylation is promising in the application of liquid biopsy-based cancer diagnosis (<xref rid="btac783-B19" ref-type="bibr">Dor and Cedar, 2018</xref>; <xref rid="btac783-B63" ref-type="bibr">Yu <italic toggle="yes">et al.</italic>, 2020</xref>). CanMethdb provides abundant annotations for genome-wide DNA methylation in cancers. Thus, researchers can screen key CpGs and related genes, important chromatin regions, or TFs in different cancer types with CanMethdb to facilitate in-depth research in identifying putative biomarkers in cancer diagnoses. Continuous efforts will be made to update the platform with available data and improve the functional properties of the CanMethdb database.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btac783_Supplementary_Data</label>
      <media xlink:href="btac783_supplementary_data.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec>
    <title>Funding</title>
    <p>This work was supported by National Natural Science Foundation of China [62171166, 62272212, 62225109 and 62072095]; Natural Science Foundation for Distinguished Young Scholars of Heilongjiang Province of China [JQ2020C004]; Research Foundation of the First Affiliated Hospital of University of South China for Advanced Talents [20210002-1005 and USCAT-2021-01]; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, China [KF202005]; Wu Liande Youth Science Research Fund of Harbin Medical University (Daqing) [JFWLD202001]; Heilongjiang Provincial Postdoctoral Science Foundation [LBH-Z19075]; and China Postdoctoral Science Foundation [2019M661311]; Hunan Provincial Base for Scientific and Technological Innovation Cooperation [2019CB1009].</p>
    <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
  </sec>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btac783-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andersson</surname><given-names>R.</given-names></string-name></person-group><etal>et al</etal> (<year>2014</year>) <article-title>An atlas of active enhancers across human cell types and tissues</article-title>. <source>Nature</source>, <volume>507</volume>, <fpage>455</fpage>–<lpage>461</lpage>.<pub-id pub-id-type="pmid">24670763</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aran</surname><given-names>D.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes</article-title>. <source>Genome Biol</source>., <volume>14</volume>, <fpage>R21</fpage>.<pub-id pub-id-type="pmid">23497655</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baek</surname><given-names>S.J.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>MENT: methylation and expression database of normal and tumor tissues</article-title>. <source>Gene</source>, <volume>518</volume>, <fpage>194</fpage>–<lpage>200</lpage>.<pub-id pub-id-type="pmid">23219992</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bailey</surname><given-names>T.L.</given-names></string-name></person-group><etal>et al</etal> (<year>2009</year>) <article-title>MEME SUITE: tools for motif discovery and searching</article-title>. <source>Nucleic Acids Res</source>., <volume>37</volume>, <fpage>W202</fpage>–<lpage>W208</lpage>.<pub-id pub-id-type="pmid">19458158</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barrett</surname><given-names>T.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>NCBI GEO: archive for functional genomics data sets–update</article-title>. <source>Nucleic Acids Res</source>., <volume>41</volume>, <fpage>D991</fpage>–<lpage>D995</lpage>.<pub-id pub-id-type="pmid">23193258</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bonev</surname><given-names>B.</given-names></string-name>, <string-name><surname>Cavalli</surname><given-names>G.</given-names></string-name></person-group> (<year>2016</year>) <article-title>Organization and function of the 3D genome</article-title>. <source>Nat. Rev. Genet</source>., <volume>17</volume>, <fpage>772</fpage>.<pub-id pub-id-type="pmid">28704353</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boyes</surname><given-names>J.</given-names></string-name>, <string-name><surname>Bird</surname><given-names>A.</given-names></string-name></person-group> (<year>1991</year>) <article-title>DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein</article-title>. <source>Cell</source>, <volume>64</volume>, <fpage>1123</fpage>–<lpage>1134</lpage>.<pub-id pub-id-type="pmid">2004419</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cerami</surname><given-names>E.G.</given-names></string-name></person-group><etal>et al</etal> (<year>2011</year>) <article-title>Pathway commons, a web resource for biological pathway data</article-title>. <source>Nucleic Acids Res</source>., <volume>39</volume>, <fpage>D685</fpage>–<lpage>D690</lpage>.<pub-id pub-id-type="pmid">21071392</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>L.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma</article-title>. <source>Gut</source>, <volume>69</volume>, <fpage>630</fpage>–<lpage>640</lpage>.<pub-id pub-id-type="pmid">31409603</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>X.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>DNA methylation profiles capturing breast cancer heterogeneity</article-title>. <source>BMC Genomics</source>, <volume>20</volume>, <fpage>823</fpage>.<pub-id pub-id-type="pmid">31699026</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheneby</surname><given-names>J.</given-names></string-name></person-group><etal>et al</etal> (<year>2018</year>) <article-title>ReMap 2018: an updated atlas of regulatory regions from an integrative analysis of DNA-binding ChIP-seq experiments</article-title>. <source>Nucleic Acids Res</source>., <volume>46</volume>, <fpage>D267</fpage>–<lpage>D275</lpage>.<pub-id pub-id-type="pmid">29126285</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chepelev</surname><given-names>I.</given-names></string-name></person-group><etal>et al</etal> (<year>2012</year>) <article-title>Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization</article-title>. <source>Cell Res</source>., <volume>22</volume>, <fpage>490</fpage>–<lpage>503</lpage>.<pub-id pub-id-type="pmid">22270183</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chu</surname><given-names>A.Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2017</year>) <article-title>Epigenome-wide association studies identify DNA methylation associated with kidney function</article-title>. <source>Nat. Commun</source>., <volume>8</volume>, <fpage>1286</fpage>.<pub-id pub-id-type="pmid">29097680</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B14">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Corces</surname><given-names>M.R.</given-names></string-name></person-group><etal>et al</etal>; <collab>The Cancer Genome Atlas Analysis Network</collab>. (<year>2018</year>) <article-title>The chromatin accessibility landscape of primary human cancers</article-title>. <source>Science</source>, <volume>362</volume>, <fpage>eaav1898</fpage>.<pub-id pub-id-type="pmid">30361341</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dahlin</surname><given-names>A.M.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>Relation between established glioma risk variants and DNA methylation in the tumor</article-title>. <source>PLoS One</source>, <volume>11</volume>, <fpage>e0163067</fpage>.<pub-id pub-id-type="pmid">27780202</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dekker</surname><given-names>J.</given-names></string-name>, <string-name><surname>Mirny</surname><given-names>L.</given-names></string-name></person-group> (<year>2016</year>) <article-title>The 3D genome as moderator of chromosomal communication</article-title>. <source>Cell</source>, <volume>164</volume>, <fpage>1110</fpage>–<lpage>1121</lpage>.<pub-id pub-id-type="pmid">26967279</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ding</surname><given-names>W.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>DNMIVD: DNA methylation interactive visualization database</article-title>. <source>Nucleic Acids Res</source>., <volume>48</volume>, <fpage>D856</fpage>–<lpage>D862</lpage>.<pub-id pub-id-type="pmid">31598709</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dor</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Cedar</surname><given-names>H.</given-names></string-name></person-group> (<year>2018</year>) <article-title>Principles of DNA methylation and their implications for biology and medicine</article-title>. <source>Lancet</source>, <volume>392</volume>, <fpage>777</fpage>–<lpage>786</lpage>.<pub-id pub-id-type="pmid">30100054</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B6661385">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fleischer</surname>,<given-names>T.</given-names></string-name></person-group><etal>et al</etal> (<year>2017</year>) <article-title>DNA methylation at enhancers identifies distinct breast cancer lineages</article-title>. <source>Nat. Commun.</source>, <volume>8</volume>. <pub-id pub-id-type="doi">10.1038/s41467-017-00510-x</pub-id>.</mixed-citation>
    </ref>
    <ref id="btac783-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ganesh</surname><given-names>S.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>Quantum scale organic semiconductors for SERS detection of DNA methylation and gene expression</article-title>. <source>Nat. Commun</source>., <volume>11</volume>, <fpage>1135</fpage>.<pub-id pub-id-type="pmid">32111825</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grant</surname><given-names>C.E.</given-names></string-name></person-group><etal>et al</etal> (<year>2011</year>) <article-title>FIMO: scanning for occurrences of a given motif</article-title>. <source>Bioinformatics</source>, <volume>27</volume>, <fpage>1017</fpage>–<lpage>1018</lpage>.<pub-id pub-id-type="pmid">21330290</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B21">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Haeussler</surname><given-names>M.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>The UCSC Genome Browser database: 2019 update</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D853</fpage>–<lpage>D858</lpage>.<pub-id pub-id-type="pmid">30407534</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B22">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harrow</surname><given-names>J.</given-names></string-name></person-group><etal>et al</etal> (<year>2012</year>) <article-title>GENCODE: the reference human genome annotation for the ENCODE project</article-title>. <source>Genome Res</source>., <volume>22</volume>, <fpage>1760</fpage>–<lpage>1774</lpage>.<pub-id pub-id-type="pmid">22955987</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B23">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname><given-names>X.</given-names></string-name></person-group><etal>et al</etal> (<year>2008</year>) <article-title>MethyCancer: the database of human DNA methylation and cancer</article-title>. <source>Nucleic Acids Res</source>., <volume>36</volume>, <fpage>D836</fpage>–<lpage>D841</lpage>.<pub-id pub-id-type="pmid">17890243</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B24">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hnisz</surname><given-names>D.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>Super-enhancers in the control of cell identity and disease</article-title>. <source>Cell</source>, <volume>155</volume>, <fpage>934</fpage>–<lpage>947</lpage>.<pub-id pub-id-type="pmid">24119843</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B25">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hu</surname><given-names>S.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>DNA methylation presents distinct binding sites for human transcription factors</article-title>. <source>Elife</source>, <volume>2</volume>, <fpage>e00726</fpage>.<pub-id pub-id-type="pmid">24015356</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B26">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>H.Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>MethHC 2.0: information repository of DNA methylation and gene expression in human cancer</article-title>. <source>Nucleic Acids Res</source>., <volume>49</volume>, <fpage>D1268</fpage>–<lpage>D1275</lpage>.<pub-id pub-id-type="pmid">33270889</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B27">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>W.Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>MethHC: a database of DNA methylation and gene expression in human cancer</article-title>. <source>Nucleic Acids Res</source>., <volume>43</volume>, <fpage>D856</fpage>–<lpage>D861</lpage>.<pub-id pub-id-type="pmid">25398901</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B28">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>SEdb: a comprehensive human super-enhancer database</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D235</fpage>–<lpage>D243</lpage>.<pub-id pub-id-type="pmid">30371817</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B29">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kanehisa</surname><given-names>M.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>KEGG as a reference resource for gene and protein annotation</article-title>. <source>Nucleic Acids Res</source>., <volume>44</volume>, <fpage>D457</fpage>–<lpage>D462</lpage>.<pub-id pub-id-type="pmid">26476454</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B30">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Klose</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Bird</surname><given-names>A.P.</given-names></string-name></person-group> (<year>2006</year>) <article-title>Genomic DNA methylation: the mark and its mediators</article-title>. <source>Trends Biochem. Sci</source>., <volume>31</volume>, <fpage>89</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">16403636</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B31">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>S.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>A deep learning and similarity-based hierarchical clustering approach for pathological stage prediction of papillary renal cell carcinoma</article-title>. <source>Comput. Struct. Biotechnol. J</source>., <volume>18</volume>, <fpage>2639</fpage>–<lpage>2646</lpage>.<pub-id pub-id-type="pmid">33033583</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B32">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lhoumaud</surname><given-names>P.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>EpiMethylTag: simultaneous detection of ATAC-seq or ChIP-seq signals with DNA methylation</article-title>. <source>Genome Biol</source>., <volume>20</volume>, <fpage>248</fpage>.<pub-id pub-id-type="pmid">31752933</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B33">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>G.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>Joint profiling of DNA methylation and chromatin architecture in single cells</article-title>. <source>Nat. Methods</source>, <volume>16</volume>, <fpage>991</fpage>–<lpage>993</lpage>.<pub-id pub-id-type="pmid">31384045</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B34">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>M.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>EWAS Atlas: a curated knowledgebase of epigenome-wide association studies</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D983</fpage>–<lpage>D988</lpage>.<pub-id pub-id-type="pmid">30364969</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B35">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname><given-names>X.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>OncoBase: a platform for decoding regulatory somatic mutations in human cancers</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D1044</fpage>–<lpage>D1055</lpage>.<pub-id pub-id-type="pmid">30445567</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B36">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lieberman-Aiden</surname><given-names>E.</given-names></string-name></person-group><etal>et al</etal> (<year>2009</year>) <article-title>Comprehensive mapping of long-range interactions reveals folding principles of the human genome</article-title>. <source>Science</source>, <volume>326</volume>, <fpage>289</fpage>–<lpage>293</lpage>.<pub-id pub-id-type="pmid">19815776</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B37">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>Methylation-eQTL analysis in cancer research</article-title>. <source>Bioinformatics</source>, <volume>37</volume>, <fpage>4014</fpage>–<lpage>4022</lpage>.<pub-id pub-id-type="pmid">34117863</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B38">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Loven</surname><given-names>J.</given-names></string-name></person-group><etal>et al</etal> (<year>2013</year>) <article-title>Selective inhibition of tumor oncogenes by disruption of super-enhancers</article-title>. <source>Cell</source>, <volume>153</volume>, <fpage>320</fpage>–<lpage>334</lpage>.<pub-id pub-id-type="pmid">23582323</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B39">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matys</surname><given-names>V.</given-names></string-name></person-group><etal>et al</etal> (<year>2006</year>) <article-title>TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes</article-title>. <source>Nucleic Acids Res</source>., <volume>34</volume>, <fpage>D108</fpage>–<lpage>D110</lpage>.<pub-id pub-id-type="pmid">16381825</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B40">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maurano</surname><given-names>M.T.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>Role of DNA methylation in modulating transcription factor occupancy</article-title>. <source>Cell Rep</source>., <volume>12</volume>, <fpage>1184</fpage>–<lpage>1195</lpage>.<pub-id pub-id-type="pmid">26257180</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B41">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mei</surname><given-names>S.</given-names></string-name></person-group><etal>et al</etal> (<year>2017</year>) <article-title>Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse</article-title>. <source>Nucleic Acids Res</source>., <volume>45</volume>, <fpage>D658</fpage>–<lpage>D662</lpage>.<pub-id pub-id-type="pmid">27789702</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B42">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Oki</surname><given-names>S.</given-names></string-name></person-group><etal>et al</etal> (<year>2018</year>) <article-title>ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data</article-title>. <source>EMBO Rep</source>., <volume>19</volume>, <fpage>e46255</fpage>.<pub-id pub-id-type="pmid">30413482</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B43">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qian</surname><given-names>F.C.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>SEanalysis: a web tool for super-enhancer associated regulatory analysis</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>W248</fpage>–<lpage>W255</lpage>.<pub-id pub-id-type="pmid">31028388</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B44">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qin</surname><given-names>T.</given-names></string-name></person-group><etal>et al</etal> (<year>2022</year>) <article-title>Comprehensive enhancer-target gene assignments improve gene set level interpretation of genome-wide regulatory data</article-title>. <source>Genome Biol</source>., <volume>23</volume>, <fpage>105</fpage>.<pub-id pub-id-type="pmid">35473573</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B45">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Quinlan</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Hall</surname><given-names>I.M.</given-names></string-name></person-group> (<year>2010</year>) <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>. <source>Bioinformatics</source>, <volume>26</volume>, <fpage>841</fpage>–<lpage>842</lpage>.<pub-id pub-id-type="pmid">20110278</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B46">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rao</surname><given-names>S.S.</given-names></string-name></person-group><etal>et al</etal> (<year>2014</year>) <article-title>A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping</article-title>. <source>Cell</source>, <volume>159</volume>, <fpage>1665</fpage>–<lpage>1680</lpage>.<pub-id pub-id-type="pmid">25497547</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B47">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ritchie</surname><given-names>M.E.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res</source>., <volume>43</volume>, <fpage>e47</fpage>.<pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B48">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Saint-Andre</surname><given-names>V.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>Models of human core transcriptional regulatory circuitries</article-title>. <source>Genome Res</source>., <volume>26</volume>, <fpage>385</fpage>–<lpage>396</lpage>.<pub-id pub-id-type="pmid">26843070</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B49">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Silva</surname><given-names>T.C.</given-names></string-name></person-group><etal>et al</etal> (<year>2022</year>) <article-title>MethReg: estimating the regulatory potential of DNA methylation in gene transcription</article-title>. <source>Nucleic Acids Res</source>., <volume>50</volume>, <fpage>e51</fpage>.<pub-id pub-id-type="pmid">35100398</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B50">
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Smyth</surname><given-names>G.K.</given-names></string-name></person-group><etal>et al</etal> (<year>2005</year>) <part-title>limma: linear models for microarray data</part-title>. In: <person-group person-group-type="editor"><string-name><surname>Gentleman</surname><given-names>R.</given-names></string-name></person-group> (ed.) <source>Bioinformatics and Computational Biology Solutions Using R and Bioconductor</source>. <publisher-name>Springer</publisher-name>, <publisher-loc>New York, NY</publisher-loc>, pp. <fpage>397</fpage>–<lpage>420</lpage>.</mixed-citation>
    </ref>
    <ref id="btac783-B51">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Teng</surname><given-names>L.</given-names></string-name></person-group><etal>et al</etal> (<year>2016</year>) <article-title>4DGenome: a comprehensive database of chromatin interactions</article-title>. <source>Bioinformatics</source>, <volume>32</volume>, <fpage>2727</fpage>.<pub-id pub-id-type="pmid">27371723</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B52">
      <mixed-citation publication-type="journal"><collab>The ENCODE Project Consortium</collab>. (<year>2012</year>) <article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>. <source>Nature</source>, <volume>489</volume>, <fpage>57</fpage>–<lpage>74</lpage>.<pub-id pub-id-type="pmid">22955616</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B53">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thurman</surname><given-names>R.E.</given-names></string-name></person-group><etal>et al</etal> (<year>2012</year>) <article-title>The accessible chromatin landscape of the human genome</article-title>. <source>Nature</source>, <volume>489</volume>, <fpage>75</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="pmid">22955617</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B54">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tomczak</surname><given-names>K.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge</article-title>. <source>Contemp. Oncol. (Pozn)</source>, <volume>19</volume>, <fpage>A68</fpage>–<lpage>A77</lpage>.<pub-id pub-id-type="pmid">25691825</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B55">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>F.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>ATACdb: a comprehensive human chromatin accessibility database</article-title>. <source>Nucleic Acids Res</source>., <volume>49</volume>, <fpage>D55</fpage>–<lpage>D64</lpage>.<pub-id pub-id-type="pmid">33125076</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B56">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2018</year>) <article-title>The 3D Genome Browser: a web-based browser for visualizing 3D genome organization and long-range chromatin interactions</article-title>. <source>Genome Biol</source>., <volume>19</volume>, <fpage>151</fpage>.<pub-id pub-id-type="pmid">30286773</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B57">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiong</surname><given-names>Y.</given-names></string-name></person-group><etal>et al</etal> (<year>2017</year>) <article-title>DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database</article-title>. <source>Nucleic Acids Res</source>., <volume>45</volume>, <fpage>D888</fpage>–<lpage>D895</lpage>.<pub-id pub-id-type="pmid">27899673</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B58">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiong</surname><given-names>Z.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>EWAS Data Hub: a resource of DNA methylation array data and metadata</article-title>. <source>Nucleic Acids Res</source>., <volume>48</volume>, <fpage>D890</fpage>–<lpage>D895</lpage>.<pub-id pub-id-type="pmid">31584095</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B59">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xuan Lin</surname><given-names>Q.X.</given-names></string-name></person-group><etal>et al</etal> (<year>2019</year>) <article-title>MethMotif: an integrative cell specific database of transcription factor binding motifs coupled with DNA methylation profiles</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>D145</fpage>–<lpage>D154</lpage>.<pub-id pub-id-type="pmid">30380113</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B60">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>X.</given-names></string-name></person-group><etal>et al</etal> (<year>2017</year>) <article-title>Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns</article-title>. <source>Brief. Bioinform</source>., <volume>18</volume>, <fpage>761</fpage>–<lpage>773</lpage>.<pub-id pub-id-type="pmid">27436122</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B61">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yao</surname><given-names>L.</given-names></string-name></person-group><etal>et al</etal> (<year>2015</year>) <article-title>Inferring regulatory element landscapes and transcription factor networks from cancer methylomes</article-title>. <source>Genome Biol</source>., <volume>16</volume>, <fpage>105</fpage>.<pub-id pub-id-type="pmid">25994056</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B62">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yevshin</surname><given-names>I.</given-names></string-name></person-group><etal>et al</etal> (<year>2017</year>) <article-title>GTRD: a database of transcription factor binding sites identified by ChIP-seq experiments</article-title>. <source>Nucleic Acids Res</source>., <volume>45</volume>, <fpage>D61</fpage>–<lpage>D67</lpage>.<pub-id pub-id-type="pmid">27924024</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B63">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>F.</given-names></string-name></person-group><etal>et al</etal> (<year>2020</year>) <article-title>CFEA: a cell-free epigenome atlas in human diseases</article-title>. <source>Nucleic Acids Res</source>., <volume>48</volume>, <fpage>D40</fpage>–<lpage>D44</lpage>.<pub-id pub-id-type="pmid">31428785</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B64">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>C.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>SurvivalMeth: a web server to investigate the effect of DNA methylation-related functional elements on prognosis</article-title>. <source>Brief. Bioinform</source>., <volume>22</volume>, <fpage>bbaa162</fpage>.<pub-id pub-id-type="pmid">32778890</pub-id></mixed-citation>
    </ref>
    <ref id="btac783-B65">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>X.</given-names></string-name></person-group><etal>et al</etal> (<year>2021</year>) <article-title>The regulatory pattern of target gene expression by aberrant enhancer methylation in glioblastoma</article-title>. <source>BMC Bioinformatics</source>, <volume>22</volume>, <fpage>420</fpage>.<pub-id pub-id-type="pmid">34482818</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
